Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-22-009351
Filing Date
2022-04-20
Accepted
2022-04-20 17:14:03
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A acrx20220419_10ka.htm   iXBRL 10-K/A 525766
2 EXHIBIT 31.1 ex_361252.htm EX-31.1 3322
3 EXHIBIT 31.2 ex_361253.htm EX-31.2 3213
  Complete submission text file 0001437749-22-009351.txt   787956

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acrx-20211231.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20211231_def.xml EX-101.DEF 17163
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20211231_lab.xml EX-101.LAB 23278
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20211231_pre.xml EX-101.PRE 18144
9 EXTRACTED XBRL INSTANCE DOCUMENT acrx20220419_10ka_htm.xml XML 7996
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35068 | Film No.: 22838944
SIC: 2834 Pharmaceutical Preparations